| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
1982-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1984-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1984-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE31730-E |
| titleOfInvention |
Process for the preparation of the crystalline monohydrate of 7-(D-α-aα-(p-hydroxyphenyl)acetamido)-3-methyl-3-cephem-4-carboxylic acid |
| abstract |
A novel crystalline monohydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-methyl-3-caphem-4-carboxylic acid is prepared and found to be astable useful form of the cephalosporin antibiotic especially advantageous for pharmaceutical formulations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5604222-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5578721-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5034522-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5574154-A |
| priorityDate |
1976-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |